Amgen Inc. is hiring a Clinical Research Medical Director for the Type 2 Diabetes (T2D) space. In this remote position within the United States, you will provide clinical leadership on studies for the maridebart cafraglutide (AMG 133) global development program in obesity and related metabolic diseases. Reporting to the Global Development Lead, you will be instrumental in shaping the phase 3 evidence generation plan.
What You'll Do
- Provide clinical and scientific knowledge into the development, design, delivery, and communication of the global evidence generation plan for the maridebart cafraglutide phase 3 program.
- Support cross-functional and global collaborations to integrate broad medical, scientific, and commercial input.
- Participate and provide clinical input into safety and regulatory interactions.
- Interpret and communicate clinical trial data.
- Author clinical study reports, publications, and regulatory submissions.
- Develop key opinion leaders and make scientific presentations at advisory boards, scientific meetings, and external committees.
- Provide clinical content input to materials for Scientific Affairs and the Commercial Organization.
- Contribute to Target Product Profile (TPP) and Global Product Safety (GPS) development.
- Create development options and present to the Global Dev Review Committee (GDRC) and Obesity Leadership Team (OLT).
- Interact with Therapeutic Area leadership and teams to develop options.
- Interact with groups such as the Center for Design Analysis (CfDA), Center for Observational Research (CfOR), and Clinical Pharmacology Modeling & Simulation (CPMS) to bring innovative later development options.
What We're Looking For
- MD or DO degree from an accredited medical school.
- 2 years of clinical research experience and/or basic science research.
Nice to Have
- Type 2 Diabetes experience.
- Three (3) or more years of clinical research experience in the biopharmaceutical industry (biotech, pharmaceutical, or CRO).
- Five or more years of clinical research and/or basic science research combined with clinical teaching and patient care activities.
- Strong and versatile clinical development experience in endocrinology or cardiology and accreditation in a relevant sub-specialty.
- Knowledge of pharmaceutical product development, product lifecycle, and commercialization processes.
- Experience developing study concepts and clinical trial designs with cross-functional input for Phase 2 and/or 3 trials in diabetes or obesity.
- Knowledge of Good Clinical Practices (GCP), FDA and EMEA/CHMP regulations, and applicable international regulatory requirements.
- Leadership experience or potential as a medical expert in a complex matrix environment.
- Ability to effectively present ideas and document complex medical concepts in written and oral communication.
- Strong interpersonal skills and problem-solving abilities with superior judgment.
Team & Environment
You will join the Obesity Therapeutic Area, reporting directly to the Global Development Lead for the assigned indication.
Benefits & Compensation
- Compensation range: $261,969 - $329,723.
- Comprehensive benefits including a Retirement and Savings Plan with generous company contributions, group medical, dental, and vision coverage, life and disability insurance, and flexible spending accounts.
- A discretionary annual bonus program.
- Stock-based long-term incentives.
- Award-winning time-off plans and bi-annual company-wide shutdowns.
- Flexible work models, including remote work arrangements.
Work Mode
This is a fully remote position for candidates located within the United States.
Amgen is an Equal Opportunity employer and will consider you without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status.
